Thyrocare Technologies Ltd

Thyrocare Tech. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Thyrocare Technologies Ltd

₹ 660 2.42%
24 Apr - close price
thyrocare.com BSE: 539871 NSE : THYROCARE
About

Thyrocare Technologies is engaged in the business of healthcare industry and is involved in providing quality diagnostic services at affordable costs to patients, laboratories and hospitals in India.

Key Points

World’s leading Diagnostic center Incorporated in the year 1996, as a single economical thyroid testing center in Mumbai and now has become the world's leading Diagnostic chain which offers a wide range of medical diagnostic tests and management of diseases and disorders. [1]

Website BSE NSE
  • Market Cap ₹ 3,495 Cr.
  • Current Price ₹ 660
  • High / Low ₹ 723 / 432
  • Stock P/E 56.5
  • Book Value ₹ 89.2
  • Dividend Yield 2.73 %
  • ROCE 15.3 %
  • ROE 10.6 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 110%

Cons

  • Stock is trading at 7.40 times its book value
  • The company has delivered a poor sales growth of 7.95% over past five years.
  • Promoters have pledged 100% of their holding.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
132 139 159 169 110 123 119 125 117 125 124 136 123
83 88 89 82 74 86 85 96 91 102 90 100 92
Operating Profit 49 51 71 87 36 37 34 30 26 23 33 37 31
OPM % 37% 36% 44% 52% 33% 30% 28% 24% 22% 18% 27% 27% 25%
3 2 3 2 1 2 1 1 1 2 0 2 2
Interest 0 0 1 1 1 1 1 1 1 1 1 1 1
Depreciation 6 6 6 7 7 9 8 8 9 9 9 9 11
Profit before tax 46 47 67 82 29 29 27 22 18 15 24 28 21
Tax % 26% 25% 28% 26% 22% 31% 24% 35% 28% 33% 31% 28% 28%
34 35 48 61 23 20 20 14 13 10 17 20 15
EPS in Rs 6.48 6.68 9.15 11.45 4.27 3.85 3.80 2.70 2.39 1.88 3.16 3.83 2.81
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
109 134 150 180 235 298 332 370 401 474 562 486 508
60 71 81 109 140 182 193 222 233 304 330 371 385
Operating Profit 49 64 69 71 95 115 139 148 168 171 232 115 123
OPM % 45% 47% 46% 40% 40% 39% 42% 40% 42% 36% 41% 24% 24%
5 18 7 13 6 -16 21 14 -35 12 7 5 6
Interest 0 0 0 0 1 0 0 0 1 1 3 5 3
Depreciation 2 3 6 11 11 12 12 14 20 21 28 34 38
Profit before tax 52 78 69 73 89 87 148 147 112 161 207 81 88
Tax % 33% 27% 33% 33% 34% 46% 35% 35% 29% 26% 27% 30%
35 57 46 49 59 47 96 95 79 120 152 57 62
EPS in Rs 32.32 52.04 42.28 9.75 10.94 8.69 17.87 18.04 15.01 22.65 28.74 10.76 11.68
Dividend Payout % 0% 0% 0% 157% 91% 115% 56% 111% 33% 110% 52% 167%
Compounded Sales Growth
10 Years: 14%
5 Years: 8%
3 Years: 7%
TTM: 5%
Compounded Profit Growth
10 Years: 0%
5 Years: -10%
3 Years: -19%
TTM: -8%
Stock Price CAGR
10 Years: %
5 Years: 6%
3 Years: -13%
1 Year: 51%
Return on Equity
10 Years: 21%
5 Years: 22%
3 Years: 22%
Last Year: 11%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 11 11 11 51 54 54 54 53 53 53 53 53 53
Reserves 92 149 195 229 322 364 400 403 325 393 468 468 419
25 25 25 0 0 0 0 0 9 10 21 21 42
10 11 14 14 39 26 31 32 55 73 55 70 56
Total Liabilities 137 197 246 293 414 444 485 488 442 528 597 612 571
20 75 87 83 93 89 103 108 112 119 149 157 154
CWIP 0 10 6 6 1 2 0 1 4 8 2 1 1
Investments 24 77 119 162 266 299 315 289 239 274 259 274 226
93 34 33 42 55 54 68 89 88 127 186 180 190
Total Assets 137 197 246 293 414 444 485 488 442 528 597 612 571

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
37 46 46 36 67 89 112 97 136 111 106 120
-18 -88 -52 -21 -19 -40 -48 -3 27 -53 -12 -32
0 1 0 -23 -45 -48 -65 -96 -163 -58 -87 -88
Net Cash Flow 19 -42 -6 -7 3 1 -1 -3 1 0 6 1

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 11 9 12 9 11 7 10 11 14 34 60 63
Inventory Days 64 54 54 47 54 64 66 54 60 50 54 63
Days Payable 7 2 13 5 8 4 23 19 62 48 30 52
Cash Conversion Cycle 68 61 53 51 57 68 53 46 12 37 84 74
Working Capital Days 91 19 22 52 15 28 11 4 -9 9 49 38
ROCE % 47% 50% 33% 27% 27% 29% 33% 31% 36% 37% 41% 15%

Shareholding Pattern

Numbers in percentages

Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
66.14% 71.22% 71.18% 71.18% 71.18% 71.14% 71.14% 71.14% 71.14% 71.14% 71.11% 71.11%
13.19% 12.10% 12.02% 12.68% 12.82% 10.42% 10.13% 9.99% 3.44% 3.46% 3.35% 2.90%
6.38% 6.59% 6.71% 6.88% 7.15% 9.14% 8.68% 8.45% 13.46% 13.33% 13.89% 14.88%
14.29% 10.09% 10.09% 9.26% 8.85% 9.29% 10.04% 10.40% 11.95% 12.08% 11.64% 11.11%
No. of Shareholders 53,14062,93665,76966,31566,43171,41275,82274,38676,29272,00068,84464,823

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Concalls